hydralazine has been researched along with wortmannin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Esaki, M; Fujiwara, H; Fujiwara, T; Kanamori, H; Kondo, T; Li, L; Li, Y; Maruyama, R; Minatoguchi, S; Miyata, S; Nakagawa, M; Ogino, A; Ohno, T; Okada, H; Takemura, G | 1 |
1 other study(ies) available for hydralazine and wortmannin
Article | Year |
---|---|
ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart.
Topics: Androstadienes; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; Cell Proliferation; Fibrosis; Granulation Tissue; Hydralazine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Receptor, Angiotensin, Type 1; Receptor, IGF Type 1; Signal Transduction; Time Factors; Ventricular Function, Left; Ventricular Remodeling; Wortmannin | 2007 |